2025-12-17 10.9.52.83
Code of China Chinese Classification Professional Classification ICS Classification Latest News Value-added Services

Position: Chinese Standard in English/T/CMEAS 040-2025
T/CMEAS 040-2025   Arteriosclerotic cardiovascular disease risk assessment criteria for metabolic dysfunction associated fatty liver disease (English Version)
Standard No.: T/CMEAS 040-2025 Status:valid remind me the status change

Email:

Target Language:English File Format:PDF
Word Count: Translation Price(USD): remind me the price change

Email:

Implemented on:2025-3-10 Delivery:

→ → →

,,2025-3-10,D9ABF8B1C8B093FD1752657690300
Standard No.: T/CMEAS 040-2025
English Name: Arteriosclerotic cardiovascular disease risk assessment criteria for metabolic dysfunction associated fatty liver disease
Chinese Name: 代谢相关脂肪性肝病的动脉粥样硬化性心血管疾病风险评估规范
Professional Classification: T/    Social Organization Standard
Source Content Issued by: CMEAS
Issued on: 2025-03-10
Implemented on: 2025-3-10
Status: valid
Target Language: English
File Format: PDF
本文件规定了代谢相关脂肪性肝病(MAFLD)的动脉粥样硬化性心血管疾病(ASCVD)风险评估的综合临床实践要求。
本文件适用于全国各级疾病预防机构和医疗机构对代谢相关脂肪性肝病和动脉粥样硬化性心血管疾病风险的评估和治疗。
Code of China
Standard
T/CMEAS 040-2025  Arteriosclerotic cardiovascular disease risk assessment criteria for metabolic dysfunction associated fatty liver disease (English Version)
Standard No.T/CMEAS 040-2025
Statusvalid
LanguageEnglish
File FormatPDF
Word Count words
Price(USD)
Implemented on2025-3-10
Deliveryvia email in business day
Detail of T/CMEAS 040-2025
Standard No.
T/CMEAS 040-2025
English Name
Arteriosclerotic cardiovascular disease risk assessment criteria for metabolic dysfunction associated fatty liver disease
Chinese Name
代谢相关脂肪性肝病的动脉粥样硬化性心血管疾病风险评估规范
Chinese Classification
Professional Classification
T/
ICS Classification
Issued by
CMEAS
Issued on
2025-03-10
Implemented on
2025-3-10
Status
valid
Superseded by
Superseded on
Abolished on
Superseding
Language
English
File Format
PDF
Word Count
words
Price(USD)
Keywords
T/CMEAS 040-2025, T/CMEAST 040-2025, TCMEAST 040-2025, T/CMEAS040-2025, T/CMEAS 040, T/CMEAS040, T/CMEAST040-2025, T/CMEAST 040, T/CMEAST040, TCMEAST040-2025, TCMEAST 040, TCMEAST040
Introduction of T/CMEAS 040-2025
本文件规定了代谢相关脂肪性肝病(MAFLD)的动脉粥样硬化性心血管疾病(ASCVD)风险评估的综合临床实践要求。
本文件适用于全国各级疾病预防机构和医疗机构对代谢相关脂肪性肝病和动脉粥样硬化性心血管疾病风险的评估和治疗。
Contents of T/CMEAS 040-2025
About Us   |    Contact Us   |    Terms of Service   |    Privacy   |    Cancellation & Refund Policy   |    Payment
Tel: +86-10-8572 5655 | Fax: +86-10-8581 9515 | Email: coc@codeofchina.com | QQ: 672269886
Copyright: Beijing COC Tech Co., Ltd. 2008-2040
 
 
Keywords:
T/CMEAS 040-2025, T/CMEAST 040-2025, TCMEAST 040-2025, T/CMEAS040-2025, T/CMEAS 040, T/CMEAS040, T/CMEAST040-2025, T/CMEAST 040, T/CMEAST040, TCMEAST040-2025, TCMEAST 040, TCMEAST040